NAGE · Niagen Bioscience, Inc.
$3.40
-0.09 (-2.58%)
At close · Jul 22
Market Cap
$270.39M
Shares
79.64M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
57/100
Short interest 5.5% of shares — P76
Days to cover 5.6 — P84
Price vs VWAP -11.0% — P27
Short-volume trend -15.9% — P10
Short interest change -2.3% — P38
Worst FTD 0.22% of shares — P83
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 4,394,606 | 4,498,798 | -104,192 | 5.57 |
| 2026-06-15 | 4,498,798 | 4,715,950 | -217,152 | 6.90 |
| 2026-05-29 | 4,715,950 | 4,990,181 | -274,231 | 4.75 |
| 2026-05-15 | 4,990,181 | 5,401,652 | -411,471 | 3.95 |
| 2026-04-30 | 5,401,652 | 5,453,364 | -51,712 | 7.95 |
| 2026-04-15 | 5,453,364 | 5,496,661 | -43,297 | 9.12 |
| 2026-03-31 | 5,496,661 | 5,578,868 | -82,207 | 4.45 |
| 2026-03-13 | 5,578,868 | 6,457,826 | -878,958 | 2.20 |
| 2026-02-27 | 6,457,826 | 6,494,766 | -36,940 | 7.16 |
| 2026-02-13 | 6,494,766 | 5,935,773 | +558,993 | 7.18 |
| 2026-01-30 | 5,935,773 | 5,801,384 | +134,389 | 8.27 |
| 2026-01-15 | 5,801,384 | 5,674,234 | +127,150 | 6.52 |
| 2025-12-31 | 5,674,234 | 5,589,502 | +84,732 | 7.09 |
| 2025-12-15 | 5,589,502 | 5,521,464 | +68,038 | 7.63 |
| 2025-11-28 | 5,521,464 | 5,634,298 | -112,834 | 7.03 |
| 2025-11-14 | 5,634,298 | 5,076,831 | +557,467 | 4.69 |
| 2025-10-31 | 5,076,831 | 4,172,117 | +904,714 | 5.63 |
| 2025-10-15 | 4,172,117 | 3,751,819 | +420,298 | 2.72 |
| 2025-09-30 | 3,751,819 | 3,939,095 | -187,276 | 3.86 |
| 2025-09-15 | 3,939,095 | 4,342,306 | -403,211 | 4.46 |
| 2025-08-29 | 4,342,306 | 4,091,073 | +251,233 | 5.63 |
| 2025-08-15 | 4,091,073 | 3,850,928 | +240,145 | 2.89 |
| 2025-07-31 | 3,850,928 | 3,492,241 | +358,687 | 3.21 |
Showing 1–23 of 23 settlements
Key facts
CIK
1386570
CUSIP
171077407
13F (30d)
18 filings
18 filers
Visit website
Investor relations